CDLX CARDLYTICS INC revenue, earnings and financials

For the quarter ended June 30, 2026, CARDLYTICS INC reported revenue of $36.9M (down 36.5% from a year earlier), net income of −$14.9M and diluted EPS of n/a; over the last four quarters revenue was $190M and net income −$101M; for the fiscal year ended December 2025 revenue was $233M, down 16.2% on the year before.

CDLX annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $233M, gross profit n/a, operating income −$102M, net income −$104M (margin -44.6%), EPS −$1.95
• Fiscal year ended Dec 2024: revenue $278M, gross profit n/a, operating income −$195M, net income −$189M (margin -67.9%), EPS −$3.91
• Fiscal year ended Dec 2023: revenue $309M, gross profit n/a, operating income −$136M, net income −$135M (margin -43.7%), EPS −$3.69
• Fiscal year ended Dec 2022: revenue $299M, gross profit n/a, operating income −$458M, net income −$465M (margin -155.8%), EPS −$13.92
• Fiscal year ended Dec 2021: revenue $267M, gross profit n/a, operating income −$123M, net income −$129M (margin -48.1%), EPS −$3.99

CDLX quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $36.9M (down 36.5% year over year), net income −$14.9M, EPS n/a
• Quarter ended Mar 31, 2026: revenue $34.3M (down 39.2% year over year), net income −$4.48M, EPS n/a
• Quarter ended Dec 31, 2025 (from the annual report): revenue $66.8M (down 9.8% year over year), net income −$8.76M, EPS −$0.15
• Quarter ended Sep 30, 2025: revenue $52.0M (down 22.4% year over year), net income −$72.7M, EPS −$1.36
• Quarter ended Jun 30, 2025: revenue $58.0M (down 16.7% year over year), net income −$9.28M, EPS −$0.18
• Quarter ended Mar 31, 2025: revenue $56.4M (down 16.5% year over year), net income −$13.3M, EPS −$0.26
• Quarter ended Dec 31, 2024 (from the annual report): revenue $74.0M (down 17.0% year over year), net income −$15.3M, EPS −$0.36
• Quarter ended Sep 30, 2024: revenue $67.1M (down 15.1% year over year), net income −$145M, EPS −$2.90
• Quarter ended Jun 30, 2024: revenue $69.6M (down 9.2% year over year), net income −$4.26M, EPS −$0.09
• Quarter ended Mar 31, 2024: revenue $67.6M (up 5.1% year over year), net income −$24.3M, EPS −$0.56
• Quarter ended Dec 31, 2023 (from the annual report): revenue $89.2M (up 8.1% year over year), net income −$101M, EPS −$2.79
• Quarter ended Sep 30, 2023: revenue $79.0M (up 8.7% year over year), net income −$24.0M, EPS −$0.63
• Quarter ended Jun 30, 2023: revenue $76.7M (up 1.7% year over year), net income −$23.5M, EPS −$0.67
• Quarter ended Mar 31, 2023: revenue $64.3M (down 5.3% year over year), net income $13.6M, EPS $0.40
• Quarter ended Dec 31, 2022 (from the annual report): revenue $82.5M (down 8.4% year over year), net income −$378M, EPS −$11.27
• Quarter ended Sep 30, 2022: revenue $72.7M (up 11.9% year over year), net income $6.27M, EPS $0.19
• Quarter ended Jun 30, 2022: revenue $75.4M (up 28.1% year over year), net income −$126M, EPS −$3.75
• Quarter ended Mar 31, 2022: revenue $67.9M (up 27.6% year over year), net income $33.0M, EPS $0.91
• Quarter ended Dec 31, 2021 (from the annual report): revenue $90.0M, net income −$11.8M, EPS −$0.36
• Quarter ended Sep 30, 2021: revenue $65.0M, net income −$44.5M, EPS −$1.35

CDLX cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $9.29M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$8.82M, share buybacks $0
• Fiscal year ended Dec 2023: operating cash flow −$185K, share buybacks $0
• Fiscal year ended Dec 2022: operating cash flow −$53.9M, share buybacks $40.0M
• Fiscal year ended Dec 2021: operating cash flow −$38.5M, share buybacks $0

CDLX balance sheet

• Jun 30, 2026: cash $28.0M, total assets $235M, total liabilities $251M, shareholders' equity −$16.0M
• Mar 31, 2026: cash $35.7M, total assets $264M, total liabilities $268M, shareholders' equity −$4.00M
• Dec 31, 2025: cash $48.7M, total assets $286M, total liabilities $292M, shareholders' equity −$6.51M
• Sep 30, 2025: cash $44.0M, total assets $293M, total liabilities $298M, shareholders' equity −$4.70M
• Jun 30, 2025: cash $46.7M, total assets $361M, total liabilities $302M, shareholders' equity $58.7M
• Mar 31, 2025: cash $52.0M, total assets $369M, total liabilities $305M, shareholders' equity $64.1M
• Dec 31, 2024: cash $65.6M, total assets $393M, total liabilities $323M, shareholders' equity $70.0M
• Sep 30, 2024: cash $67.0M, total assets $399M, total liabilities $330M, shareholders' equity $69.7M

What is CDLX's revenue?

CARDLYTICS INC reported $190M of revenue over its last four quarters, through June 30, 2026.

Is CDLX profitable?

No. CARDLYTICS INC lost $101M over the last four quarters.

CDLX ownership and insider trades · All stocks